KUALA LUMPUR, Malaysia and SINGAPORE, May 29, 2024 (GLOBE NEWSWIRE) -- Revenue at RM6.0 billion mark for the first time Outstanding growth momentum: revenue up 16%, EBITDA up 19% Core profit or PATMI (ex EI) up 22%; Lower headline ...
Read MoreTORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Casey House – a hospital unlike any other providing care to those living with and at risk of HIV – today announces the launch of its latest advocacy campaign, Stigmavir. This initiative aims to ...
Read MoreGeneva, Switzerland, May 29, 2024 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) convened esteemed global leaders for an event on the sidelines of the 77th World Health Assembly in Geneva, Switzerland, entitled “Together for Better Liver ...
Read MoreJ&J will gain full rights to develop, manufacture and commercialize NM26 globally for the treatment of atopic dermatitis and follow-on indications Under the agreement terms, J&J will pay $1.25 billion to acquire Yellow Jersey Therapeutics, ...
Read More International analysis of mental health provision in eight G20 countries reveals stigma, a shortage of mental health professionals and inconsistent availability and quality of care are creating barriers to vital mental health care services ...
Read MoreCommitment supports at-risk and marginalized youth across Canada TORONTO , May 6, 2024 /CNW/ - Ahead of National Child and Youth Mental Health Day tomorrow, Sun Life is pleased to announce a $1,050,000 million commitment over three ...
Read MoreOTTAWA, ON , May 6, 2024 /CNW/ - Mental health issues can impact anyone, at any point in their lives, and can present in many different ways. In any given year, it can affect one in five Canadians, from all walks of life, all cultures, all ...
Read MoreProceeds from financing to support ongoing clinical development of lead program targeting PVR as well as IND-enabling activities for multiple ADC candidates TEL AVIV, Israel , May 6, 2024 /PRNewswire/ -- Guangzhou-Israel Biotechnology ...
Read More- Presentation Today, Monday, May 6, 2024 in Atlanta , Georgia - TEL AVIV, Israel , May 6, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies ...
Read MoreSubscribe to our Free Newsletters!